Dr Shona Lang has spent 8 years working in clinical epidemiology preparing systematic reviews, meta-analyses, rapid reviews, and health technology assessments to support policy making, licensing and reimbursement decisions in clinical research.
Prior to this, she was a Wellcome Fellow in cancer research and tissue development. Her focus was on alternative models to animal testing (human tissue culture, organoids, 3D models and stem cells). Using her expertise in both fields she is researching the value of evidence-based decision making in biomedical science and clinical translation and hopes to provide solutions to de-risk investment in this field.
To this end she has established QED Biomedical Ltd, which you can find on Twitter and LinkedIn, with her long-term collaborator Dr Anne Collins.
